Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists.
Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists.
复制标题
1,3-二取代吡唑外周大麻素受体部分激动剂的发现。
DOI：
10.1016/j.bmcl.2023.129430
复制
发表时间：
2023
影响因子：
2.7
通讯作者：
Maitra,Rangan
中科院分区：
文献类型：
--
作者：
Amato,George;Runyon,Scott;Vasukuttan,Vineetha;Decker,AnnM;Gay,ElaineA;Laudermilk,Lucas;Maitra,Rangan
Partial agonists of peripheral cannabinoid receptors (CBRs) have potential therapeutic applications in several medical conditions. However, (−)-trans-Δ9-tetrahydrocannabinol (THC), the principal active component of marijuana, which is a partial agonist of CB1 and CB2 penetrates the central nervous system (CNS) and produces adverse effects. Peripherally restricted partial agonists of CBRs, particularly of CB1, can be used to treat illnesses safely and effectively with a better therapeutic index. Here, we report on our efforts to synthesize pyrazole partial CBR agonists with peripheral selectivity, resulting in lead compound 40. This compound is a potent partial agonist of CB1 with ∼ 5-fold higher plasma biodistribution over brain and represents an early lead for optimization.
